Japan Digital PCR (dPCR) and Real-Time PCR (qPCR) Market to Witness Significant Growth Through 2035
Japan digital PCR (dPCR) and real-time PCR (qPCR) market is expected to witness considerable growth during the forecast period, driven by the increasing prevalence of infectious diseases, rising cancer cases, and continuous advancements in molecular diagnostic technologies. Growing adoption of quantitative PCR and digital PCR technologies in research, clinical diagnostics, and forensic applications is accelerating market demand across Japan. Additionally, increasing investments in healthcare infrastructure, expanding genomics research activities, and rising demand for accurate and rapid diagnostic solutions are further supporting the growth of reagents & consumables, instruments, and software segments in the country.
Browse the full report description of “Japan Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025” at https://www.omrglobal.com/industry-reports/japan-digital-pcr-and-real-time-pcr-market
Thermo Fisher Scientific Japan expands molecular biology workflow solutions in Japan (2025)
Thermo Fisher Scientific Inc. launched the Thermo Scientific NanoDrop Ultra spectrophotometer in Japan to improve nucleic acid workflow efficiency for PCR-based molecular testing and genomics research applications. The platform supports DNA and RNA quantification, qPCR workflow preparation, genomic research, biopharmaceutical analysis, and advanced molecular biology applications across research and clinical laboratories. The system is designed to enhance workflow accuracy, improve sample analysis efficiency, and support high-throughput laboratory environments. The expansion reflects continued investment in Japan’s molecular diagnostics, genomics, and life sciences research infrastructure.
Bio-Rad Laboratories expands Droplet Digital PCR portfolio through Stilla Technologies acquisition (2025)
Bio-Rad Laboratories, Inc. expanded its digital PCR business through the acquisition and integration of Stilla Technologies to strengthen its advanced molecular diagnostics and genomics research capabilities. The company launched the QX Continuum™ ddPCR System, QX700™ series platforms, advanced multiplex digital PCR workflows, and high-throughput dPCR solutions for research and clinical applications. The expanded portfolio is expected to improve sensitivity, precision, and scalability in nucleic acid analysis and biomarker detection. The development supports growing adoption of dPCR technologies across Japan’s genomics research, oncology testing, and molecular diagnostics sectors.
Roche Diagnostics Japan launches Digital LightCycler® Dx System in Japan (2025)
Roche Diagnostics K.K. launched the Digital LightCycler® Dx System as a medical device in Japan to strengthen the country’s advanced molecular diagnostics capabilities. The system supports high-precision digital PCR testing, multiplex nucleic acid quantification, clinical molecular diagnostics, DNA and RNA analysis, and advanced oncology and infectious disease applications. Roche developed the platform to improve diagnostic accuracy, workflow automation, and detection sensitivity in clinical laboratory environments. The launch strengthens Japan’s clinical dPCR infrastructure and expands the adoption of next-generation molecular diagnostics technologies across hospitals, diagnostic centers, and research institutions.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404